- Home
- MTLS vs OLMA Comparison
MTLS vs OLMA Comparison
Compare MTLS & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- OLMA
- Stock Information
- Founded
- MTLS 1990
- OLMA 2006
- Country
- MTLS Belgium
- OLMA United States
- Employees
- MTLS N/A
- OLMA N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- OLMA Health Care
- Exchange
- MTLS Nasdaq
- OLMA Nasdaq
- Market Cap
- MTLS 349.7M
- OLMA 378.9M
- IPO Year
- MTLS 2014
- OLMA 2020
- Fundamental
- Price
- MTLS $5.17
- OLMA $7.75
- Analyst Decision
- MTLS
- OLMA Strong Buy
- Analyst Count
- MTLS 0
- OLMA 5
- Target Price
- MTLS N/A
- OLMA $24.00
- AVG Volume (30 Days)
- MTLS 121.7K
- OLMA 1.1M
- Earning Date
- MTLS 10-23-2025
- OLMA 11-11-2025
- Dividend Yield
- MTLS N/A
- OLMA N/A
- EPS Growth
- MTLS N/A
- OLMA N/A
- EPS
- MTLS 0.11
- OLMA N/A
- Revenue
- MTLS $311,850,851.00
- OLMA N/A
- Revenue This Year
- MTLS $2.98
- OLMA N/A
- Revenue Next Year
- MTLS $7.09
- OLMA N/A
- P/E Ratio
- MTLS $47.83
- OLMA N/A
- Revenue Growth
- MTLS 2.98
- OLMA N/A
- 52 Week Low
- MTLS $3.93
- OLMA $2.86
- 52 Week High
- MTLS $9.69
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- MTLS 51.80
- OLMA 64.67
- Support Level
- MTLS $4.96
- OLMA $7.49
- Resistance Level
- MTLS $5.24
- OLMA $8.40
- Average True Range (ATR)
- MTLS 0.18
- OLMA 0.67
- MACD
- MTLS 0.02
- OLMA 0.08
- Stochastic Oscillator
- MTLS 64.29
- OLMA 75.63
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.